ArticleAmerican journal of translational research2020

Isocorydine decrease gemcitabine-resistance by inhibiting epithelial-mesenchymal transition via STAT3 in pancreatic cancer cells.

Quan-Bo Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.